Biogen Idec profits fall, as firm seeks revenue from older drugs
Biogen Idec’s third-quarter profit fell 26 percent compared to the previous year as the biotech firm took charges from its ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.